Nanopet Pharma GmbH

Nanopet Pharma GmbH is a company in Berlin, Germany that has taken part in 6 EU-funded projects since 2010, receiving €2.7M in EU funding.

EU funding received€2.7M
EU projects6
As coordinator0
Running now0
First EU project2010
Latest project2013
CountryGermany
EU registration (PIC)995066062
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Nanopet Pharma GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.7M · 6 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • NANOMAGPartner

    Nanometrology Standardization Methods for Magnetic Nanoparticles

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €492ktheir share
  • NANOATHEROPartner

    Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €512ktheir share
  • DARTRIXPartner

    DARPin Targeted Magnetic Hyperthermic Therapy for Glioblastoma

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €225ktheir share
  • IDEAPartner

    Identification, homing and monitoring of therapeutic cells for regenerative medicine – Identify, Enrich, Accelerate

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €498ktheir share
  • BIO2MAN4MRIPartner

    Biomimetic and Biomineralized Magnetic Nanoparticles for Magnetic Resonance Imaging

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €492ktheir share
  • VASCUBONEPartner

    Construction kit for tailor-made vascularized boneimplants

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €528ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • arteriosclerosis
  • bacteriology
  • biomaterials
  • drug discovery
  • magnetic resonance imaging
  • nano-materials
  • nanomedicine
  • oncology
  • pharmaceutical drugs
  • proteins
  • spintronics
  • stem cells
  • stroke

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime